BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10777567)

  • 1. Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase.
    Glover RT; Angiolieri M; Kelly S; Monaghan DT; Wang JY; Smithgall TE; Buller AL
    J Biol Chem; 2000 Apr; 275(17):12725-9. PubMed ID: 10777567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meltrin alpha cytoplasmic domain interacts with SH3 domains of Src and Grb2 and is phosphorylated by v-Src.
    Suzuki A; Kadota N; Hara T; Nakagami Y; Izumi T; Takenawa T; Sabe H; Endo T
    Oncogene; 2000 Nov; 19(51):5842-50. PubMed ID: 11127814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
    Mayer BJ; Baltimore D
    Mol Cell Biol; 1994 May; 14(5):2883-94. PubMed ID: 8164650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck.
    Briggs SD; Bryant SS; Jove R; Sanderson SD; Smithgall TE
    J Biol Chem; 1995 Jun; 270(24):14718-24. PubMed ID: 7782336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5).
    O'Connell JC; McCallum JF; McPhee I; Wakefield J; Houslay ES; Wishart W; Bolger G; Frame M; Houslay MD
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):255-61. PubMed ID: 8761480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intramolecular SH3-domain interaction regulates c-Abl activity.
    Barilá D; Superti-Furga G
    Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
    Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Abl SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding.
    Chen S; Brier S; Smithgall TE; Engen JR
    Protein Sci; 2007 Apr; 16(4):572-81. PubMed ID: 17327393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core.
    Chen S; O'Reilly LP; Smithgall TE; Engen JR
    J Mol Biol; 2008 Nov; 383(2):414-23. PubMed ID: 18775435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential SH3 domain-binding site in the Crk SH2 domain.
    Anafi M; Rosen MK; Gish GD; Kay LE; Pawson T
    J Biol Chem; 1996 Aug; 271(35):21365-74. PubMed ID: 8702917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Abl tyrosine kinase binds and phosphorylates phospholipid scramblase 1.
    Sun J; Zhao J; Schwartz MA; Wang JY; Wiedmer T; Sims PJ
    J Biol Chem; 2001 Aug; 276(31):28984-90. PubMed ID: 11390389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proline-rich sequences that bind to Src homology 3 domains with individual specificities.
    Alexandropoulos K; Cheng G; Baltimore D
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3110-4. PubMed ID: 7536925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity.
    Dai Z; Pendergast AM
    Genes Dev; 1995 Nov; 9(21):2569-82. PubMed ID: 7590236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.
    Hunter S; Burton EA; Wu SC; Anderson SM
    J Biol Chem; 1999 Jan; 274(4):2097-106. PubMed ID: 9890970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
    Ren SY; Xue F; Feng J; Skorski T
    Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
    Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-ABL tyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein.
    Zhu J; Shore SK
    Mol Cell Biol; 1996 Dec; 16(12):7054-62. PubMed ID: 8943360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitotic phosphorylation rescues Abl from F-actin-mediated inhibition.
    Woodring PJ; Hunter T; Wang JY
    J Biol Chem; 2005 Mar; 280(11):10318-25. PubMed ID: 15632178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the proline-rich region of mouse MAPKAP kinase 2: influence on catalytic properties and binding to the c-abl SH3 domain in vitro.
    Plath K; Engel K; Schwedersky G; Gaestel M
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1188-94. PubMed ID: 8093038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.